Baidu
map

胃肠外科指南

订阅

MedSci主页 / 所有栏目 / 胃肠外科指南

2021 ACG临床指南：良性肛肠疾病的管理

2021-10-01 美国胃肠病学院 The American College of Gastroenterology

良性肛肠疾病

本文主要总结了成人排便障碍、直肠疼痛综合征、痔疮、肛裂以及大便失禁的评估和管理方法，并提供相关指导建议。

中文标题：

2021 ACG临床指南：良性肛肠疾病的管理

英文标题：

ACG Clinical Guidelines: Management of Benign Anorectal Disorders

发布机构：

美国胃肠病学院

发布日期：

2021-10-01

简要介绍：

2021年10月，美国胃肠病学院(ACG)发布了良性肛肠疾病的管理指南，良性肛门指肠结构和功能紊乱在临床实践中很常见，本文主要总结了成人排便障碍、直肠疼痛综合征、痔疮、肛裂以及大便失禁的评估和管理方法，并提供相关指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=ACG_Clinical_Guidelines__Management_of_Benign.13.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0b6211c002200319, title=2021 ACG临床指南：良性肛肠疾病的管理, enTitle=ACG Clinical Guidelines: Management of Benign Anorectal Disorders, guiderFrom=The American College of Gastroenterology, authorId=0, author=, summary=本文主要总结了成人排便障碍、直肠疼痛综合征、痔疮、肛裂以及大便失禁的评估和管理方法，并提供相关指导建议。, cover=https://img.medsci.cn/2021108/1633702682137_5579292.jpg, journalId=0, articlesId=null, associationId=269, associationName=美国胃肠病学院, associationIntro=美国胃肠病学院（ACG）是公认的胃肠专业教育及大众消化道疾病的领导者。The American Journal of Gastroenterology（AJG）为该学会的官方期刊。, copyright=0, guiderPublishedTime=Fri Oct 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年10月，美国胃肠病学院(ACG)发布了良性肛肠疾病的管理指南，良性肛门指肠结构和功能紊乱在临床实践中很常见，本文主要总结了成人排便障碍、直肠疼痛综合征、痔疮、肛裂以及大便失禁的评估和管理方法，并提供相关指导建议。</span></p>, tagList=[TagDto(tagId=115701, tagName=良性肛肠疾病)], categoryList=[CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=8037, guiderKeyword=肛肠疾病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5182, appHits=82, showAppHits=0, pcHits=2102, showPcHits=5098, likes=0, shares=9, comments=7, approvalStatus=1, publishedTime=Fri Oct 08 22:18:19 CST 2021, publishedTimeString=2021-10-01, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Oct 08 22:18:14 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 06:36:16 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=ACG_Clinical_Guidelines__Management_of_Benign.13.pdf)])
ACG_Clinical_Guidelines__Management_of_Benign.13.pdf
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1081662, encodeId=5ce11081662c0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b3e6411849, createdName=ms4000000068385678, createdTime=Sun Dec 19 00:40:25 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058903, encodeId=273710589033e, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bddc5437368, createdName=ms6000001737380682, createdTime=Sat Oct 09 11:28:49 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058752, encodeId=ca9b1058e52d2, content=不断学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Fri Oct 08 22:58:56 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058769, encodeId=bd761058e6915, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Oct 08 23:56:12 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058768, encodeId=52a11058e68f8, content=呃呃呃, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Fri Oct 08 23:56:11 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
    2021-12-19 ms4000000068385678

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1081662, encodeId=5ce11081662c0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b3e6411849, createdName=ms4000000068385678, createdTime=Sun Dec 19 00:40:25 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058903, encodeId=273710589033e, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bddc5437368, createdName=ms6000001737380682, createdTime=Sat Oct 09 11:28:49 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058752, encodeId=ca9b1058e52d2, content=不断学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Fri Oct 08 22:58:56 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058769, encodeId=bd761058e6915, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Oct 08 23:56:12 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058768, encodeId=52a11058e68f8, content=呃呃呃, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Fri Oct 08 23:56:11 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
    2021-10-09 ms6000001737380682

    学习中

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1081662, encodeId=5ce11081662c0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b3e6411849, createdName=ms4000000068385678, createdTime=Sun Dec 19 00:40:25 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058903, encodeId=273710589033e, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bddc5437368, createdName=ms6000001737380682, createdTime=Sat Oct 09 11:28:49 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058752, encodeId=ca9b1058e52d2, content=不断学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Fri Oct 08 22:58:56 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058769, encodeId=bd761058e6915, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Oct 08 23:56:12 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058768, encodeId=52a11058e68f8, content=呃呃呃, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Fri Oct 08 23:56:11 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
    2021-10-08 SR~young海东

    不断学习

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1081662, encodeId=5ce11081662c0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b3e6411849, createdName=ms4000000068385678, createdTime=Sun Dec 19 00:40:25 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058903, encodeId=273710589033e, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bddc5437368, createdName=ms6000001737380682, createdTime=Sat Oct 09 11:28:49 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058752, encodeId=ca9b1058e52d2, content=不断学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Fri Oct 08 22:58:56 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058769, encodeId=bd761058e6915, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Oct 08 23:56:12 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058768, encodeId=52a11058e68f8, content=呃呃呃, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Fri Oct 08 23:56:11 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
    2021-10-08 1209e435m98(暂无昵称)

    学习了，谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1081662, encodeId=5ce11081662c0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b3e6411849, createdName=ms4000000068385678, createdTime=Sun Dec 19 00:40:25 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058903, encodeId=273710589033e, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bddc5437368, createdName=ms6000001737380682, createdTime=Sat Oct 09 11:28:49 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058752, encodeId=ca9b1058e52d2, content=不断学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Fri Oct 08 22:58:56 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058769, encodeId=bd761058e6915, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Oct 08 23:56:12 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058768, encodeId=52a11058e68f8, content=呃呃呃, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Fri Oct 08 23:56:11 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
    2021-10-08 ms1000001191450835

    呃呃呃

    0

拓展阅读

疫情期间常见肛肠疾病处理专家建议

中国医药教育协会 · 2020-07-05

肛泰栓(软膏)治疗肛肠疾病专家共识

肛泰栓(软膏)临床应用专家共识专家组 · 2022-10-18

Baidu
map
Baidu
map
Baidu
map